Publication:
De novo mutations in Plxnd1 and Rev3l cause mobius syndrome

Thumbnail Image

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Tomas-Roca, Laura
Tsaalbi-Shtylik, Anastasia
Jansen, Jacob G.
Singh, Manvendra K.
Epstein, Jonathan A.
Altunoglu, Umut
Verzijl, Harriette
Soria, Laura
van Beusekom, Ellen
Roscioli, Tony

Publication Date

Language

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Mobius syndrome (MBS) is a neurological disorder that is characterized by paralysis of the facial nerves and variable other congenital anomalies. The aetiology of this syndrome has been enigmatic since the initial descriptions by von Graefe in 1880 and by Mobius in 1888, and it has been debated for decades whether MBS has a genetic or a non-genetic aetiology. Here, we report de novo mutations affecting two genes, PLXND1 and REV3L in MBS patients. PLXND1 and REV3L represent totally unrelated pathways involved in hindbrain development: neural migration and DNA translesion synthesis, essential for the replication of endogenously damaged DNA, respectively. Interestingly, analysis of Plxnd1 and Rev3l mutant mice shows that disruption of these separate pathways converge at the facial branchiomotor nucleus, affecting either motoneuron migration or proliferation. The finding that PLXND1 and REV3L mutations are responsible for a proportion of MBS patients suggests that de novo mutations in other genes might account for other MBS patients.

Source

Publisher

Nature Publishing Group (NPG)

Subject

Multidisciplinary sciences, Molecular biology and genetics

Citation

Has Part

Source

Nature Communications

Book Series Title

Edition

DOI

10.1038/ncomms8199

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

7

Downloads

View PlumX Details